A Phase II Study of Osimertinib Combined With Platinum Plus Pemetrexed in Patients With EGFR-Mutated Advanced Non–Small-cell Lung Cancer: The OPAL Study (NEJ032C/LOGIK1801)

Hajime Asahina, Kentaro Tanaka, Satoshi Morita, Makoto Maemondo, Masahiro Seike, Isamu Okamoto, Satoshi Oizumi, Hiroshi Kagamu, Kazuhisa Takahashi, Toshiaki Kikuchi, Takeshi Isobe, Kenji Sugio, Kunihiko Kobayashi

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'A Phase II Study of Osimertinib Combined With Platinum Plus Pemetrexed in Patients With EGFR-Mutated Advanced Non–Small-cell Lung Cancer: The OPAL Study (NEJ032C/LOGIK1801)'. Together they form a unique fingerprint.

Medicine & Life Sciences